IRON - Disc Medicine, Inc.
NEXT EARNINGS:
May 5, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$110.25
DETAILS
HIGH:
$153.00
LOW:
$75.00
MEDIAN:
$112.00
CONSENSUS:
$110.25
UPSIDE:
81.39%
Market Cap:
2.32B
Volume:
528,261
Avg Volume:
700,435
52 Week Range:
30.82-99.5
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.66
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
94
IPO Date:
2020-08-12
EPS (TTM):
-6.01
P/E Ratio:
-13.21
Revenue (TTM):
N/A
Total Assets:
806.88M
Total Debt:
1.86M
Cash & Equiv:
91.14M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-27.0%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-26 | $-1.62 | $-1.69 | +4.1% | — | $150000 | — |
| 2025-11-06 | $-1.77 | $-1.48 | -19.6% | — | — | — |
| 2025-08-07 | $-1.58 | $-1.17 | -35.0% | — | — | — |
| 2025-05-07 | $-1.02 | $-0.99 | -3.0% | — | — | — |
| 2025-02-27 | $-0.98 | $-1.06 | +7.5% | — | — | — |
| 2024-11-12 | $-0.89 | $-0.98 | +9.2% | — | — | — |
| 2024-08-08 | $-1.03 | $-1.11 | +7.2% | — | — | — |
| 2024-05-09 | $-1.09 | $-1.00 | -9.0% | — | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (212.18M) | (109.36M) | (76.43M) | (46.83M) | (35.97M) | (40.84M) |
| EPS | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 | -27.02 |
| Total Assets | 806.88M | 496.77M | 368.00M | 200.21M | 92.41M | 8.32M |
| Total Debt | 1.86M | 30.00M | 2.10M | 1.33M | 7.06M | 21.64M |
| Cash & Equivalents | 91.14M | 192.43M | 360.38M | 194.61M | 88.04M | 4.50M |
| Operating Cash Flow | (180.39M) | (93.93M) | (73.46M) | (42.25M) | (27.53M) | (32.71M) |
| Free Cash Flow | (181.33M) | (94.43M) | (73.55M) | (42.40M) | (27.60M) | (32.73M) |
| FCF per Share | -5.14 | -3.42 | -3.30 | -40.79 | -34.44 | -21.65 |
| Book Value | 739.83M | 443.59M | 345.12M | 176.60M | (64.20M) | (21.86M) |
| Cash & ST Investments | 791.15M | 489.88M | 360.38M | 194.61M | 88.04M | 4.50M |
| Return on Equity | -0.29 | -0.25 | -0.22 | -0.27 | N/A | N/A |